journavx - Search News

FDA, opioid and Journavx

USA TODAY on MSN · 3h

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

New pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids

Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, surgeries, and other injuries and procedures.

Newsweek on MSN · 5h

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

1h

AbbVie, Vertex's Journavx, Exxon and Chevron: Market Minute

Yahoo Finance host Josh Lipton breaks down the day's top trending stocks and market stories in the Market Minute. AbbVie ...

Psychology Today18h

Treating Pain—Avoiding the Brain

A new class of analgesics offers an alternative, aiming to relieve pain without the risk of dependency. Journavx ...

5h

What's Happening With VRTX Stock?

With a rise in Trikafta demand, the investors have assigned a higher valuation multiple for VRTX stock. The increase in VRTX ...

4hon MSN

Brand-new painkiller approved by US health agency

Suzetrigine (Journavx) is the first non-opioid painkiller to be approved in the US in 20 years. It could help over 80 million ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results